JP2021536461A5 - - Google Patents

Info

Publication number
JP2021536461A5
JP2021536461A5 JP2021512444A JP2021512444A JP2021536461A5 JP 2021536461 A5 JP2021536461 A5 JP 2021536461A5 JP 2021512444 A JP2021512444 A JP 2021512444A JP 2021512444 A JP2021512444 A JP 2021512444A JP 2021536461 A5 JP2021536461 A5 JP 2021536461A5
Authority
JP
Japan
Prior art keywords
amino acid
composition according
reserve
nerve
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512444A
Other languages
English (en)
Japanese (ja)
Other versions
JP7589143B2 (ja
JP2021536461A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048698 external-priority patent/WO2020051051A1/en
Publication of JP2021536461A publication Critical patent/JP2021536461A/ja
Publication of JP2021536461A5 publication Critical patent/JP2021536461A5/ja
Priority to JP2024091680A priority Critical patent/JP2024113090A/ja
Application granted granted Critical
Publication of JP7589143B2 publication Critical patent/JP7589143B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021512444A 2018-09-05 2019-08-29 神経可塑性を誘導するための方法および組成物 Active JP7589143B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024091680A JP2024113090A (ja) 2018-09-05 2024-06-05 神経可塑性を誘導するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862727420P 2018-09-05 2018-09-05
US62/727,420 2018-09-05
PCT/US2019/048698 WO2020051051A1 (en) 2018-09-05 2019-08-29 Methods and compositions for inducing neural plasticity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024091680A Division JP2024113090A (ja) 2018-09-05 2024-06-05 神経可塑性を誘導するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2021536461A JP2021536461A (ja) 2021-12-27
JP2021536461A5 true JP2021536461A5 (cg-RX-API-DMAC7.html) 2022-09-06
JP7589143B2 JP7589143B2 (ja) 2024-11-25

Family

ID=69722599

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021512444A Active JP7589143B2 (ja) 2018-09-05 2019-08-29 神経可塑性を誘導するための方法および組成物
JP2024091680A Pending JP2024113090A (ja) 2018-09-05 2024-06-05 神経可塑性を誘導するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024091680A Pending JP2024113090A (ja) 2018-09-05 2024-06-05 神経可塑性を誘導するための方法および組成物

Country Status (8)

Country Link
US (2) US12138300B2 (cg-RX-API-DMAC7.html)
EP (1) EP3846838A4 (cg-RX-API-DMAC7.html)
JP (2) JP7589143B2 (cg-RX-API-DMAC7.html)
KR (1) KR102919967B1 (cg-RX-API-DMAC7.html)
CN (1) CN113260373B (cg-RX-API-DMAC7.html)
AU (1) AU2019334965B2 (cg-RX-API-DMAC7.html)
CA (1) CA3111512A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020051051A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024373065A1 (en) * 2023-11-01 2026-05-21 Biocells (Beijing) Biotech Co., Ltd. Polypeptide derivative, pharmaceutical composition thereof and use thereof
AU2025218273A1 (en) * 2024-02-07 2026-08-13 Dks Co. Ltd. Cyclic peptide derivative composition for improving brain function

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945108A1 (de) 1979-11-08 1981-05-21 Interatom Internationale Atomreaktorbau Gmbh, 5060 Bergisch Gladbach Faltenbalgkompensator
FR2641360B1 (fr) 1988-12-29 1991-02-22 Commissariat Energie Atomique Compensateur de dilatation monte entre deux tuyauteries
US5804604A (en) * 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
EP0721352A4 (en) 1993-10-01 1998-07-01 Univ New York NEW PHOSPHOTYROSINE PHOSPHATASE - -g (s) WITH RECEPTOR FUNCTION
DE60023920T2 (de) 1999-08-27 2006-07-20 Sugen, Inc., South San Francisco Phosphatmimetika und Verfahren zur Behandlung mit Phosphataseinhibitoren HIBITOREN
CA2417454A1 (en) * 2000-07-31 2002-02-07 Active Motif Peptide-mediated delivery of molecules into cells
WO2002083182A2 (en) 2001-04-12 2002-10-24 Mcgill University The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification
US7829087B2 (en) 2001-07-09 2010-11-09 Elan Pharmaceuticals, Inc. Methods of treating cognitive impairment
KR100814109B1 (ko) 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
WO2007089945A2 (en) 2006-02-02 2007-08-09 The Trustees Of Columbia University In The City Of New York Treating diseases by targeting silt3
KR100999043B1 (ko) 2007-12-04 2010-12-09 한국생명공학연구원 융합 단백질을 사용하지 않는 인간 단백질 타이로신탈인산화 효소의 활성 도메인 대량 생산 방법
WO2010129681A1 (en) 2009-05-05 2010-11-11 Van Andel Research Institute Methods for treating autophagy-related disorders
CA2764545C (en) 2009-06-15 2019-05-14 Katholieke Universiteit Leuven, K.U.Leuven R&D Bace1 inhibitory antibodies
US20120231014A1 (en) 2009-08-18 2012-09-13 Case Western Reserve University Neural Regeneration
US20130171163A1 (en) 2010-08-06 2013-07-04 Marschall Runge Inhibition of LAR Phosphatase to Enhance Therapeutic Angiogenesis
CA2827383A1 (en) 2011-02-18 2012-08-23 President And Fellows Of Harvard College Molecular switch for neuronal outgrowth
ES2745539T3 (es) 2012-03-19 2020-03-02 Buck Inst Res Aging Inhibidores de BACE específicos de APP (ASBI) y uso de los mismos
CA3233345A1 (en) 2012-04-09 2013-10-17 Case Western Reserve University Compositions and methods for inhibiting the activity of lar family phosphatases
US20150084328A1 (en) 2013-09-24 2015-03-26 Witzenmann Gmbh Compensator arrangement

Similar Documents

Publication Publication Date Title
JP7829511B2 (ja) Larファミリーホスファターゼの活性を阻害する組成物及び方法
Filbin Recapitulate development to promote axonal regeneration: good or bad approach?
JP2022502056A5 (cg-RX-API-DMAC7.html)
JP2023538422A5 (cg-RX-API-DMAC7.html)
KR102354845B1 (ko) 인간화 항 clever-1 항체 및 이의 용도
JP2017518043A5 (cg-RX-API-DMAC7.html)
RU2021130306A (ru) Композиции il-12, нацеленные на edb
JPWO2019156137A5 (cg-RX-API-DMAC7.html)
JP2015522576A5 (cg-RX-API-DMAC7.html)
US9809823B2 (en) DNA aptamers for promoting remyelination
RU2010144014A (ru) Применение пегилированных вариантов ифр-i для лечения нейромышечных расстройств
JP2006506942A5 (cg-RX-API-DMAC7.html)
JP2020522566A5 (cg-RX-API-DMAC7.html)
IL273538B2 (en) Anti-trkb monoclonal antibodies and methods of use
JP2021531834A5 (cg-RX-API-DMAC7.html)
CA2342770A1 (en) Ly6h gene
CN107583034A (zh) 生长分化因子11在制备缺血性脑中风疾病药物中的应用
JP2024518826A5 (cg-RX-API-DMAC7.html)
RU2012153703A (ru) Соединения двухцепочечных рнк к rhoa и их применение
RU2569302C2 (ru) Соединения и фармацевтические комбинации для лечения нейродегенеративных и ишемических болезней мозга
JP2017524727A5 (cg-RX-API-DMAC7.html)
Mukherjee et al. Myelin associated inhibitory proteins as a therapeutic target for healing of CNS injury
US9060977B2 (en) Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation
CN106928322A (zh) 一种具有抗脑缺血作用的融合多肽及其应用
WO2008057609A4 (en) Methods of treating neuronal disorders using mntf peptides and analogs thereof